Can I Take Vitamin B12 with Adderall XR?

Why This Question Comes Up

Patients prescribed Adderall XR for ADHD or narcolepsy frequently ask whether their daily vitamin B12 supplement could interact with the stimulant. The concern is understandable. Mixed amphetamine salts affect neurotransmitter systems, gastrointestinal motility, and appetite, all of which could theoretically alter how a vitamin is absorbed or used.

The Short Answer

No published case reports, pharmacokinetic studies, or FDA safety communications describe an adverse interaction between cobalamin and mixed amphetamine salts. The Natural Medicines Comprehensive Database does not list this combination as having a clinically significant interaction at any severity level. The Mayo Clinic drug interaction checker returns no results for this pair.

Why Patients Still Worry

Online forums conflate two separate issues: vitamin B12 interactions with metformin (which is well-documented) and vitamin B12 interactions with stimulants (which is not). Metformin reduces ileal absorption of the B12-intrinsic factor complex, a mechanism confirmed in a 2006 randomized trial (N=390) showing a 19% drop in serum B12 over 4.3 years [1]. Adderall XR does not share this mechanism.

How Adderall XR Works (and Where B12 Fits In)

Mixed amphetamine salts increase synaptic concentrations of dopamine and norepinephrine by promoting vesicular release and blocking reuptake [2]. The drug is absorbed in the gastrointestinal tract, reaches peak plasma levels in about 7 hours for the extended-release formulation, and is primarily excreted renally.

Amphetamine Pharmacokinetics

Adderall XR uses a dual-bead system: 50% of the dose releases immediately, and 50% releases roughly 4 hours later. Absorption occurs throughout the small intestine. Urinary pH affects elimination half-life. Acidic urine accelerates clearance (t½ ~7 to 8 hours), while alkaline urine slows it (t½ up to 11 to 14 hours) [2].

B12 Pharmacokinetics

Vitamin B12 absorption is a multi-step process. Stomach acid frees protein-bound cobalamin from food. Free B12 then binds to intrinsic factor (IF) secreted by gastric parietal cells. The B12-IF complex is absorbed in the terminal ileum through receptor-mediated endocytosis [3]. Passive diffusion accounts for roughly 1 to 2% of a large oral dose, which is why high-dose supplements (500 to 1,000 mcg) can still raise serum levels even without intrinsic factor.

No Overlapping Pathways

The two substances do not share transporters, metabolizing enzymes, or binding proteins. Amphetamines are metabolized primarily via CYP2D6 and hepatic oxidation. B12 is processed through a completely separate pathway involving transcobalamin II and cellular uptake in the liver and bone marrow. There is no competition for absorption sites, no enzyme induction or inhibition, and no protein-binding displacement.

Pharmacokinetic vs. Pharmacodynamic Interaction Analysis

A drug-supplement interaction can be pharmacokinetic (one substance alters the absorption, distribution, metabolism, or excretion of the other) or pharmacodynamic (both act on the same physiological target, amplifying or opposing effects). Neither applies here.

Pharmacokinetic Assessment

Amphetamines do raise gastric pH slightly through sympathomimetic effects on the GI tract. A higher gastric pH could theoretically reduce the acid-dependent release of protein-bound B12 from food. This effect is clinically negligible for two reasons. First, the pH change from therapeutic amphetamine doses is far smaller than what proton pump inhibitors produce, and even PPIs cause B12 deficiency only after prolonged use exceeding 2 to 3 years [4]. Second, crystalline B12 in supplements is already in free form and does not require stomach acid for release.

Amphetamines also slow gastric emptying at high doses. Delayed gastric emptying could marginally extend B12 contact time in the stomach but does not impair ileal absorption. No clinical data show reduced B12 bioavailability from stimulant use.

Pharmacodynamic Assessment

B12 functions as a cofactor for methionine synthase and methylmalonyl-CoA mutase. These enzymes operate in one-carbon metabolism and the citric acid cycle, pathways that do not overlap with catecholamine release or reuptake. There is no pharmacodynamic combination or antagonism between the two.

The American Society of Health-System Pharmacists (ASHP) drug information monograph for amphetamine salts does not list any vitamin or mineral among its clinically significant interactions [2].

Why B12 Status Still Matters for Adderall XR Users

The absence of a direct interaction does not mean B12 status is irrelevant. Stimulant therapy creates indirect nutritional risks that clinicians should monitor.

Appetite Suppression and Dietary Gaps

Appetite loss is the most common side effect of mixed amphetamine salts, reported in 22% of children and 33% of adults in clinical trials submitted to the FDA [5]. Patients who eat less consume fewer animal-source foods (meat, dairy, eggs), which are the primary dietary sources of B12. A 2013 cross-sectional analysis of NHANES data found that adults consuming fewer than 1,200 calories per day had 2.1 times the odds of serum B12 <200 pg/mL compared to those eating above 2,000 calories [6].

Overlapping Neuropsychiatric Symptoms

B12 deficiency produces fatigue, difficulty concentrating, irritability, and mood changes [3]. These symptoms overlap considerably with undertreated ADHD. A patient whose stimulant "stops working" may actually have developed subclinical B12 deficiency rather than true pharmacological tolerance.

Dr. Uma Naidoo, a Harvard nutritional psychiatrist, has noted: "Before adjusting a stimulant dose for perceived tolerance, I check B12, folate, ferritin, and vitamin D. Correcting a nutritional deficit can restore medication response without increasing the stimulant." [7]

The Metformin Confound

An increasing number of ADHD patients also take metformin for type 2 diabetes, prediabetes, or off-label metabolic management. Metformin reduces B12 absorption by 10 to 30%, and a Diabetes Prevention Program (DPP) Outcomes Study analysis found that 4.3% of metformin-treated participants developed biochemical B12 deficiency over 5 years versus 2.3% on placebo [8]. If you take Adderall XR and metformin, B12 monitoring becomes a higher priority, not because of the stimulant but because of the biguanide.

The American Diabetes Association Standards of Care (2024) recommends periodic B12 measurement in patients on long-term metformin, especially those with anemia or peripheral neuropathy [8].

Dosing and Administration Guidance

B12 Dosing for General Supplementation

For patients without documented deficiency, 500 to 1,000 mcg of oral cyanocobalamin or methylcobalamin daily is a common supplementation dose. The NIH Office of Dietary Supplements sets the Recommended Dietary Allowance (RDA) at 2.4 mcg for adults, but therapeutic supplementation doses are higher because oral bioavailability is only 1 to 2% via passive diffusion [3].

B12 Dosing for Confirmed Deficiency

Patients with serum B12 <200 pg/mL or elevated methylmalonic acid (>0.4 µmol/L) typically start with 1,000 mcg oral daily for 1 to 3 months, then reassess. Intramuscular injections (1,000 mcg cyanocobalamin) given weekly for 4 weeks, then monthly, remain the standard for pernicious anemia or severe malabsorption [3].

Timing Relative to Adderall XR

No dose-separation window is required. You can take B12 at the same time as Adderall XR. Taking B12 with a meal improves absorption of food-bound forms and reduces GI upset from high-dose supplements. Since many patients take Adderall XR with breakfast, co-administration at that time is practical.

One consideration: extremely high doses of vitamin C (above 1,000 mg) taken simultaneously with Adderall XR can acidify urine and increase amphetamine clearance [2]. Vitamin B12 does not have this effect. Do not confuse the two.

Monitoring Recommendations

Who Needs B12 Testing

Not every patient on Adderall XR needs routine B12 screening. Testing is warranted when one or more of the following apply:

• Significant appetite loss lasting more than 3 months on stimulant therapy
• Concurrent metformin use
• Vegetarian or vegan diet
• Age over 50 (gastric acid and intrinsic factor production decline)
• History of gastric surgery, celiac disease, or Crohn disease affecting the terminal ileum
• New-onset fatigue, paresthesias, or cognitive complaints that do not match ADHD symptom patterns

Which Labs to Order

Serum B12 alone has limited sensitivity. Approximately 25 to 50% of patients with true tissue-level deficiency have serum B12 values in the low-normal range (200 to 400 pg/mL) [9]. Adding methylmalonic acid (MMA) and homocysteine improves diagnostic accuracy. Elevated MMA (>0.4 µmol/L) with a low-normal B12 confirms functional deficiency.

The National Institutes of Health notes: "Methylmalonic acid is the most specific marker of B12 deficiency at the tissue level and should be measured when serum B12 is between 200 and 400 pg/mL" [9].

Monitoring Schedule

For patients on combined stimulant therapy and metformin, check B12 and MMA at baseline, 12 months, and annually thereafter. For stimulant-only patients with dietary risk factors, a baseline level and recheck at 12 months is reasonable. If supplementation is started for low levels, recheck at 3 months to confirm repletion.

Special Populations

Children and Adolescents

Adderall XR is approved for ADHD in children aged 6 and older. Growth velocity monitoring is already standard in pediatric stimulant prescribing. B12 deficiency in children can impair neurodevelopment and cause megaloblastic anemia [10]. Pediatric patients on stimulants who show poor weight gain, restricted food variety, or unexplained macrocytosis (MCV >100 fL) should have B12 checked.

The pediatric RDA for B12 is 1.8 mcg (ages 9 to 13) and 2.4 mcg (ages 14 and older). Supplementation doses in children are typically 250 to 500 mcg daily when deficiency is identified.

Older Adults

Adults over 60 have a 10 to 15% prevalence of low B12 due to atrophic gastritis reducing acid-dependent absorption [11]. Adding a stimulant's appetite-suppressing effects on top of age-related malabsorption creates a compounding risk. The CDC's Second Nutrition Report documented that serum B12 <200 pg/mL was found in 1 in 31 adults over 50 in NHANES 1999-2002 [11].

Pregnancy

Adderall XR is classified as FDA pregnancy category C. B12 requirements increase to 2.6 mcg daily during pregnancy. If a patient becomes pregnant while on mixed amphetamine salts, the prescribing discussion is about the stimulant, not the B12. Continue B12 supplementation as part of prenatal care.

What to Do If You Are Already Taking Both

If you have been taking vitamin B12 alongside Adderall XR without problems, there is no reason to change anything. The combination is safe. No published evidence from PubMed, the FDA Adverse Event Reporting System (FAERS), or the Natural Medicines database identifies a signal of harm.

If you notice new symptoms like tingling in your hands or feet, persistent fatigue unrelated to sleep, or a sore/swollen tongue, these could point to B12 deficiency independent of any drug interaction. Ask your prescriber to check serum B12 and MMA levels before attributing these symptoms to Adderall XR side effects.

Patients taking Adderall XR, metformin, and a proton pump inhibitor simultaneously face the highest risk of B12 depletion. Both metformin and PPIs independently reduce B12 absorption through different mechanisms [4][8]. In this triple-therapy scenario, 1,000 mcg of oral B12 daily or periodic intramuscular injections may be appropriate.